← FDA Drug Approvals (Drugs@FDA)

EXJADE

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2005-11-02

Drug application

FDA Application #

NDA021882

Application type

New Drug Application

Brand name

EXJADE

Generic name

DEFERASIROX

Active ingredients

DEFERASIROX

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2005-11-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown